Résumé : The loss of neuronal cells in the central nervous system may happen in numerous neurodegenerative illnesses. Alzheimer's Disease (AD) is an intricate, irreversible, dynamic neurodegenerative sickness. It is the main source of age-related dementia, influencing roughly 5.3 million individuals in the United States alone. Promotion is a typical feeble ailment in individuals more than 65 years, bringing on disability described by decrease in memory, failure to learn and do every day exercises, intellectual weakness and influences the personal satisfaction of patients. Pathologic qualities of AD are an irregular development of specific proteins called Beta-amyloid "plaques" and Tau "Tangles" in the mind. Notwithstanding, current treatments against AD are just to calm manifestations and palliative yet are not the cure and a few promising medications competitors have fizzled in late clinical trials. There is consequently a critical need to enhance our comprehension for pathogenesis of this sickness, making new and creative prescient models with powerful treatments. As of late, stem cell treatment has been appeared to have a potential way to deal with different illnesses, including neurodegenerative disorders. In light of the far reaching nature of AD pathology, stem cell substitution procedures have been seen as an extraordinarily difficult and impossible treatment approach. Stem Cell may likewise offer an effective new way to deal with model and concentrate AD. Patient derived induced Pluripotent Stem Cells (iPSCs), for instance, may propel our comprehension of disease mechanism. In this review we will examine the capability of stem cells to help in these testing tries.